Initially filed in 2020, this lawsuit against the federal government argues that the ACA's mandated coverage of HIV pre-exposure prophylaxis (PReP) drugs ... lawsuit's laundry list of preventative ...
GSK’s majority-owned HIV unit ViiV has agreed licensing deals with a trio of generic manufacturers to make its recently-approved long-acting drug for pre-exposure prophylaxis (PrEP) available in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback